Opko Health Inc

Financials

Cash from operating activities 45.71 M44.41 M34.55 M83.42 M34.65 M25.92 M 178.54 M Cash from investing activities 224.67 M115.99 M40.53 M-2.83 M194.65 M-2.05 M 230.3 M Cash from financing activities 206.14 M-40.47 M4.02 M79.49 M16.21 M18.34 M 118.06 M Free cash flow 37.77 M39 M31.36 M80.14 M31.51 M23.25 M 166.26 M

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

OPK

Financials

Opko Health Inc

ニュース

OPK Q4 Earnings & Revenues Beat Estimates, Gross Margin Contracts

OPKO Health, Inc. (OPK) Q4 2025 Earnings Call Transcript

【決算速報】オプコ・ヘルス、売上高は予想を上回り、利益は予想を上回る結果に

Opko Health earnings beat by $0.03, revenue topped estimates

Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026?

H.C. ウェインライトがOpko Healthの株式評価を「買い」で再確認

Opko Health stock rating reiterated at Buy by H.C. Wainwright

OPKOとEnteraが副甲状腺機能低下症治療のための経口PTH開発で提携拡大

OPKO Health: Deeply Mispriced Ahead Of Major Catalysts (NASDAQ:OPK)

OPKO Health, Inc. (OPK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

OrthoPediatrics (KIDS) Moves 9.8% Higher: Will This Strength Last?

OPKO Health Bets on RAYALDEE and Pipeline Progress for 2026 Growth